Inventor · disambiguated record
Deyi Zhang
Also filed as: ZHANG DEYI
13 granted patents·3 pending applications·59 citations·filing 2003–2019
88Inventor score
Files withLILLY CO ELI10ALLEN JOHN GORDON1BEIJING PEARL BIOTECHNOLOGY LLC1CB THERAPEUTICS INC1COHEN MICHAEL PHILIP1
Top patents by PatentIndex Score
16 records- 0188US7423050B2Pyridinoylpiperidines as 5-HT1F agonistsLILLY CO ELI·Filed 2003·Granted Sep 9, 2008·23 cites·10 claims
- 0281US8748459B2Pyridinoylpiperidines as 5-HT1F agonistsCOHEN MICHAEL PHILIP·Filed 2012·Granted Jun 10, 2014·6 cites·3 claims
- 0379US7291632B2Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonistsLILLY CO ELI·Filed 2004·Granted Nov 6, 2007·11 cites·12 claims
- 0478US7608629B2(Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-HT1F agonistsLILLY CO ELI·Filed 2004·Granted Oct 27, 2009·12 cites·8 claims
- 0577US8022062B26-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonistsLILLY CO ELI·Filed 2005·Granted Sep 20, 2011·4 cites·22 claims
- 0674US9359338B2Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agentsCROWN BIOSCIENCE INC TAIWAN·Filed 2013·Granted Jun 7, 2016·2 cites·32 claims
- 0763US2015376178A1Pyridinoylpiperidines As 5-HT1F AgonistsLILLY CO ELI·Filed 2014·Application pending·0 cites
- 0862US7312236B2Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-HT1F agonistsLILLY CO ELI·Filed 2004·Granted Dec 25, 2007·1 cites·10 claims
- 0957US2017044136A1Pyridinoylpiperidines As 5-HT1F AgonistsLILLY CO ELI·Filed 2016·Application pending·0 cites
- 1056US11127535B2Ferroelectric enhanced solar cell and preparation method thereofUNIV HUAZHONG SCIENCE TECH·Filed 2019·Granted Sep 21, 2021·0 cites·8 claims
- 1156US9840477B2Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agentsCB THERAPEUTICS INC·Filed 2016·Granted Dec 12, 2017·0 cites·11 claims
- 1253US7754742B2Imidazole carboxamidesLILLY CO ELI·Filed 2009·Granted Jul 13, 2010·0 cites·16 claims
- 1348US2011034511A1Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonistsLILLY CO ELI·Filed 2010·Application pending·0 cites
- 1442US7981882B26-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonistsLILLY CO ELI·Filed 2006·Granted Jul 19, 2011·0 cites·8 claims
- 1539US8580780B26 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonistALLEN JOHN GORDON·Filed 2011·Granted Nov 12, 2013·0 cites·21 claims
- 1626US10023593B2ALK kinase inhibitor, and preparation method and uses thereofBEIJING PEARL BIOTECHNOLOGY LLC·Filed 2015·Granted Jul 17, 2018·0 cites·37 claims
Join the waitlist — get patent alerts
Get an alert when Deyi Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →